SGLT2 inhibitors: the story continues to unfold

被引:3
|
作者
Pina, Ileana L. [1 ]
机构
[1] Cent Michigan Univ, Coll Med, 2627 Fairmount Blvd, Midlands, MI 48640 USA
关键词
HEART-FAILURE; SERUM POTASSIUM; OUTCOMES;
D O I
10.1093/eurheartj/ehab561
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4902 / 4904
页数:3
相关论文
共 50 条
  • [21] Renal and cardiac effects of SGLT2 inhibitors
    Menne J.
    Der Nephrologe, 2017, 12 (2): : 90 - 96
  • [22] The Role of SGLT2 Inhibitors in Vascular Aging
    Liu, Le
    Ni, Yu-Qing
    Zhan, Jun-Kun
    Liu, You-Shuo
    AGING AND DISEASE, 2021, 12 (05): : 1323 - 1336
  • [23] Perioperative Ketoacidosis under SGLT2 Inhibitors
    Buck, Sandra
    Russo, Sebastian G.
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2021, 56 (10): : 704 - 708
  • [24] Roles for SGLT2 Inhibitors in Cardiorenal Disease
    Green, Jennifer B.
    McCullough, Peter A.
    CARDIORENAL MEDICINE, 2022, 12 (03) : 81 - 93
  • [25] SGLT2 Inhibitors: Benefit/Risk Balance
    Scheen, Andre J.
    CURRENT DIABETES REPORTS, 2016, 16 (10)
  • [26] A review of cardiovascular benefits of SGLT2 inhibitors
    Zhang, Yingxia
    Han, Qinghua
    MEDICINE, 2022, 101 (36) : E30310
  • [27] Clinical prospective of SGLT2 inhibitors in atherosclerosis
    Capuano, Annalisa
    Clementi, Emilio
    Paolisso, Giuseppe
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [28] SGLT2 inhibitors and diabetic retinopathy progression
    Nadelmann, Jennifer B.
    Miller, Charles G.
    Mcgeehan, Brendan
    Yu, Yinxi
    Vanderbeek, Brian L.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (03) : 753 - 758
  • [29] SGLT2 Inhibitors in Type 2 Diabetes Mellitus
    Ferrannini, Giulia
    Savarese, Gianluigi
    Cosentino, Francesco
    HEART FAILURE CLINICS, 2022, 18 (04) : 551 - 559
  • [30] SGLT2 inhibitors, sodium and off-target effects: an overview
    De Pascalis, Antonio
    Cianciolo, Giuseppe
    Capelli, Irene
    Brunori, Giuliano
    La Manna, Gaetano
    JOURNAL OF NEPHROLOGY, 2021, 34 (03) : 673 - 680